Phipps Amber R, Paradis Melisa, Peterson Kimberly A, Jensen Jill, Nielsen Katie, Hall Mel, Simonsen Kari, Norton Bridget M
Jt Comm J Qual Patient Saf. 2018 Jun;44(6):334-340. doi: 10.1016/j.jcjq.2017.12.006. Epub 2018 May 3.
A freestanding children's hospital evaluated the impact of a patient safety program on serious safety events (SSEs) and hospital-acquired conditions (HACs).
The No Harm Patient Safety Program was developed throughout the organization using a multifaceted approach that included safety moments, leadership rounding, cause analysis changes, event reporting enhancements, error prevention training, leadership training, identifying priority HACs, Eye on Safety Campaign, and safety coaches. The organization set strategic goals for improvement of SSEs and priority HACs.
The rate of SSEs decreased from 0.19 in 2014 to 0.09 in 2015. The rate significantly declined from 2015 to 2016 to a rate of 0.00, for a rate difference of -0.00009 (95% confidence interval [CI]: -0.00016, -0.00002; p = 0.012). The organization reached two years without an SSE in July 2017. The central line-associated bloodstream infection rate significantly declined from 2.8 per 1,000 line-days in 2015 to 1.6 in 2016, for a difference of -0.00118 (95% CI: -0.002270, -0.00008; p = 0.036). Surgical site infection rates declined from a 2015 rate of 3.8 infections per 100 procedures to a 2016 rate of 2.6 (p = 0.2962), and catheter-associated urinary tract infection rates declined from a 2015 rate of 2.7 per 1,000 catheter-days to a 2016 rate of 1.4 (p = 0.2770).
The No Harm Patient Safety Program was interwoven into the organization's strategic mission and values, and key messaging was used to purposefully tie the many interventions being implemented back to it. These interventions were associated with improvements in patient safety outcomes.
一家独立儿童医院评估了一项患者安全计划对严重安全事件(SSE)和医院获得性疾病(HAC)的影响。
在整个机构中采用多方面方法制定了“无伤害患者安全计划”,包括安全时刻、领导巡查、原因分析改进、事件报告强化、错误预防培训、领导力培训、确定优先HAC、“关注安全运动”以及安全教练。该机构设定了改善SSE和优先HAC的战略目标。
SSE发生率从2014年的0.19降至2015年的0.09。从2015年到2016年显著下降至0.00,发生率差异为-0.00009(95%置信区间[CI]:-0.00016,-0.00002;p = 0.012)。该机构在2017年7月实现了连续两年无SSE。中心静脉导管相关血流感染率从2015年的每1000个导管日2.8例显著降至2016年的1.6例,差异为-0.00118(95% CI:-0.002270,-0.00008;p = 0.036)。手术部位感染率从2015年的每100例手术3.8例感染降至2016年的2.6例(p = 0.2962),导管相关尿路感染率从2015年的每1000个导管日2.7例降至2016年的1.4例(p = 0.2770)。
“无伤害患者安全计划”融入了该机构的战略使命和价值观,并通过关键信息将正在实施的众多干预措施与之有目的地联系起来。这些干预措施与患者安全结果的改善相关。